-
Published on: 01/07/2017 07:34 AMReported by: roving-eye
The Medicines and Healthcare products Regulatory Agency (MHRA) as a precautionary measure has issued updated guidance for healthcare professionals who manage patients implanted with metal-on-metal hip replacements.
Previous guidance was issued to ensure appropriate followup to monitor the potential for the already well-known risks of soft-tissue reactions. This updated guidance replaces the previous advice provided in 2012.
The key changes include additional recommendations regarding monitoring patients and are designed to ensure longer term followup is undertaken for all patients with these implants. Details of the changes are in the Medical Device Alert issued today.
Dr Neil McGuire MHRA’s Clinical Director of Medical Devices said:
We have updated the current advice to ensure patients with metal on metal hip implants continue to receive appropriate follow up to detect emerging complications should they arise.
Hip implants have positively transformed the lives of many patients who in the past were subject to increasingly severe pain and progressive disability. These use a variety of metal, plastic and ceramic components.
Although the majority of patients with these metal on metal devices have well-functioning hips, it is known some may develop soft tissue reactions related to their implant. The clinical advice we have received indicates patients will likely have the best outcomes if these problems are detected early, monitored and treated if necessary.
If you have any questions about your hip replacement, speak with your GP or implanting surgeon.
Useful links: Report Cyber Crime
| Stop Nuisance Calls & Mail
| Daily Covid Stats (updated 4pm)
| Covid excess deaths in your area
| Local NHS Resources
| What 3 Words
-
Member Post Likes / Dislikes - 0 Likes, 0 Dislikes
Check Todays Deals on Ebay.co.uk
Check Todays Deals On Amazon.co.uk
Your Comments:
-
More detailed information here https://www.fda.gov/MedicalDevices/P...cm241766.htm#4
Interesting to read, as my mother developed Motor Neurone Disease 8 years after having titanium hip replacements and died 12 months later but the possible metal toxins from these were dismissed as possible reasons for developing MND.
Yet this report from the FDA states "If you see a health care provider for the evaluation of any new or worsening symptoms outside the hip/groin area, including the symptoms related to your skin, heart, nervous system, kidneys, or thyroid gland, it is important that you tell that clinician that you have a metal-on-metal hip implant. This information may affect the types of tests that are ordered to further evaluate the cause of your symptoms."
-
Member Post Likes / Dislikes - 0 Likes, 0 Dislikes